Request for Covid-19 Impact Assessment of this Report
The United States Artemisinine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Artemisinine market, reaching US$ million by the year 2028. As for the Europe Artemisinine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Artemisinine players cover Guilin Pharmaceutical, CAT KHANH, Novanat Bioresource, and BEEPZ, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Extraction from Artemisia annua
Semisynthetic Artemisinine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Injections
Tablets
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Guilin Pharmaceutical
CAT KHANH
Novanat Bioresource
BEEPZ
KPC Pharmaceuticals
BIONEXX
Guangxi xiancaotang
Sanofi
Natural Bio-engineering
Kerui nanhai
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artemisinine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Artemisinine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Artemisinine by Country/Region, 2017, 2022 & 2028
2.2 Artemisinine Segment by Type
2.2.1 Extraction from Artemisia annua
2.2.2 Semisynthetic Artemisinine
2.3 Artemisinine Sales by Type
2.3.1 Global Artemisinine Sales Market Share by Type (2017-2022)
2.3.2 Global Artemisinine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Artemisinine Sale Price by Type (2017-2022)
2.4 Artemisinine Segment by Application
2.4.1 Injections
2.4.2 Tablets
2.4.3 Others
2.5 Artemisinine Sales by Application
2.5.1 Global Artemisinine Sale Market Share by Application (2017-2022)
2.5.2 Global Artemisinine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Artemisinine Sale Price by Application (2017-2022)
3 Global Artemisinine by Company
3.1 Global Artemisinine Breakdown Data by Company
3.1.1 Global Artemisinine Annual Sales by Company (2020-2022)
3.1.2 Global Artemisinine Sales Market Share by Company (2020-2022)
3.2 Global Artemisinine Annual Revenue by Company (2020-2022)
3.2.1 Global Artemisinine Revenue by Company (2020-2022)
3.2.2 Global Artemisinine Revenue Market Share by Company (2020-2022)
3.3 Global Artemisinine Sale Price by Company
3.4 Key Manufacturers Artemisinine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisinine Product Location Distribution
3.4.2 Players Artemisinine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Artemisinine by Geographic Region
4.1 World Historic Artemisinine Market Size by Geographic Region (2017-2022)
4.1.1 Global Artemisinine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Artemisinine Annual Revenue by Geographic Region
4.2 World Historic Artemisinine Market Size by Country/Region (2017-2022)
4.2.1 Global Artemisinine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Artemisinine Annual Revenue by Country/Region
4.3 Americas Artemisinine Sales Growth
4.4 APAC Artemisinine Sales Growth
4.5 Europe Artemisinine Sales Growth
4.6 Middle East & Africa Artemisinine Sales Growth
5 Americas
5.1 Americas Artemisinine Sales by Country
5.1.1 Americas Artemisinine Sales by Country (2017-2022)
5.1.2 Americas Artemisinine Revenue by Country (2017-2022)
5.2 Americas Artemisinine Sales by Type
5.3 Americas Artemisinine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinine Sales by Region
6.1.1 APAC Artemisinine Sales by Region (2017-2022)
6.1.2 APAC Artemisinine Revenue by Region (2017-2022)
6.2 APAC Artemisinine Sales by Type
6.3 APAC Artemisinine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Artemisinine by Country
7.1.1 Europe Artemisinine Sales by Country (2017-2022)
7.1.2 Europe Artemisinine Revenue by Country (2017-2022)
7.2 Europe Artemisinine Sales by Type
7.3 Europe Artemisinine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artemisinine by Country
8.1.1 Middle East & Africa Artemisinine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Artemisinine Revenue by Country (2017-2022)
8.2 Middle East & Africa Artemisinine Sales by Type
8.3 Middle East & Africa Artemisinine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisinine
10.3 Manufacturing Process Analysis of Artemisinine
10.4 Industry Chain Structure of Artemisinine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisinine Distributors
11.3 Artemisinine Customer
12 World Forecast Review for Artemisinine by Geographic Region
12.1 Global Artemisinine Market Size Forecast by Region
12.1.1 Global Artemisinine Forecast by Region (2023-2028)
12.1.2 Global Artemisinine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Artemisinine Forecast by Type
12.7 Global Artemisinine Forecast by Application
13 Key Players Analysis
13.1 Guilin Pharmaceutical
13.1.1 Guilin Pharmaceutical Company Information
13.1.2 Guilin Pharmaceutical Artemisinine Product Offered
13.1.3 Guilin Pharmaceutical Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Guilin Pharmaceutical Main Business Overview
13.1.5 Guilin Pharmaceutical Latest Developments
13.2 CAT KHANH
13.2.1 CAT KHANH Company Information
13.2.2 CAT KHANH Artemisinine Product Offered
13.2.3 CAT KHANH Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CAT KHANH Main Business Overview
13.2.5 CAT KHANH Latest Developments
13.3 Novanat Bioresource
13.3.1 Novanat Bioresource Company Information
13.3.2 Novanat Bioresource Artemisinine Product Offered
13.3.3 Novanat Bioresource Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novanat Bioresource Main Business Overview
13.3.5 Novanat Bioresource Latest Developments
13.4 BEEPZ
13.4.1 BEEPZ Company Information
13.4.2 BEEPZ Artemisinine Product Offered
13.4.3 BEEPZ Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 BEEPZ Main Business Overview
13.4.5 BEEPZ Latest Developments
13.5 KPC Pharmaceuticals
13.5.1 KPC Pharmaceuticals Company Information
13.5.2 KPC Pharmaceuticals Artemisinine Product Offered
13.5.3 KPC Pharmaceuticals Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 KPC Pharmaceuticals Main Business Overview
13.5.5 KPC Pharmaceuticals Latest Developments
13.6 BIONEXX
13.6.1 BIONEXX Company Information
13.6.2 BIONEXX Artemisinine Product Offered
13.6.3 BIONEXX Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 BIONEXX Main Business Overview
13.6.5 BIONEXX Latest Developments
13.7 Guangxi xiancaotang
13.7.1 Guangxi xiancaotang Company Information
13.7.2 Guangxi xiancaotang Artemisinine Product Offered
13.7.3 Guangxi xiancaotang Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Guangxi xiancaotang Main Business Overview
13.7.5 Guangxi xiancaotang Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Artemisinine Product Offered
13.8.3 Sanofi Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Natural Bio-engineering
13.9.1 Natural Bio-engineering Company Information
13.9.2 Natural Bio-engineering Artemisinine Product Offered
13.9.3 Natural Bio-engineering Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Natural Bio-engineering Main Business Overview
13.9.5 Natural Bio-engineering Latest Developments
13.10 Kerui nanhai
13.10.1 Kerui nanhai Company Information
13.10.2 Kerui nanhai Artemisinine Product Offered
13.10.3 Kerui nanhai Artemisinine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Kerui nanhai Main Business Overview
13.10.5 Kerui nanhai Latest Developments
14 Research Findings and Conclusion
Table 1. Artemisinine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Artemisinine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Extraction from Artemisia annua
Table 4. Major Players of Semisynthetic Artemisinine
Table 5. Global Artemisinine Sales by Type (2017-2022) & (K Units)
Table 6. Global Artemisinine Sales Market Share by Type (2017-2022)
Table 7. Global Artemisinine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Artemisinine Revenue Market Share by Type (2017-2022)
Table 9. Global Artemisinine Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Artemisinine Sales by Application (2017-2022) & (K Units)
Table 11. Global Artemisinine Sales Market Share by Application (2017-2022)
Table 12. Global Artemisinine Revenue by Application (2017-2022)
Table 13. Global Artemisinine Revenue Market Share by Application (2017-2022)
Table 14. Global Artemisinine Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Artemisinine Sales by Company (2020-2022) & (K Units)
Table 16. Global Artemisinine Sales Market Share by Company (2020-2022)
Table 17. Global Artemisinine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Artemisinine Revenue Market Share by Company (2020-2022)
Table 19. Global Artemisinine Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Artemisinine Producing Area Distribution and Sales Area
Table 21. Players Artemisinine Products Offered
Table 22. Artemisinine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Artemisinine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Artemisinine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Artemisinine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Artemisinine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Artemisinine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Artemisinine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Artemisinine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Artemisinine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Artemisinine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Artemisinine Sales Market Share by Country (2017-2022)
Table 35. Americas Artemisinine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Artemisinine Revenue Market Share by Country (2017-2022)
Table 37. Americas Artemisinine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Artemisinine Sales Market Share by Type (2017-2022)
Table 39. Americas Artemisinine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Artemisinine Sales Market Share by Application (2017-2022)
Table 41. APAC Artemisinine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Artemisinine Sales Market Share by Region (2017-2022)
Table 43. APAC Artemisinine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Artemisinine Revenue Market Share by Region (2017-2022)
Table 45. APAC Artemisinine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Artemisinine Sales Market Share by Type (2017-2022)
Table 47. APAC Artemisinine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Artemisinine Sales Market Share by Application (2017-2022)
Table 49. Europe Artemisinine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Artemisinine Sales Market Share by Country (2017-2022)
Table 51. Europe Artemisinine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Artemisinine Revenue Market Share by Country (2017-2022)
Table 53. Europe Artemisinine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Artemisinine Sales Market Share by Type (2017-2022)
Table 55. Europe Artemisinine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Artemisinine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Artemisinine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Artemisinine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Artemisinine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Artemisinine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Artemisinine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Artemisinine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Artemisinine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Artemisinine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Artemisinine
Table 66. Key Market Challenges & Risks of Artemisinine
Table 67. Key Industry Trends of Artemisinine
Table 68. Artemisinine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Artemisinine Distributors List
Table 71. Artemisinine Customer List
Table 72. Global Artemisinine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Artemisinine Sales Market Forecast by Region
Table 74. Global Artemisinine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Artemisinine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Artemisinine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Artemisinine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Artemisinine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Artemisinine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Artemisinine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Artemisinine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Artemisinine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Artemisinine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Artemisinine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Artemisinine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Artemisinine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Artemisinine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Artemisinine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Artemisinine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Artemisinine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Artemisinine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Guilin Pharmaceutical Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 93. Guilin Pharmaceutical Artemisinine Product Offered
Table 94. Guilin Pharmaceutical Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Guilin Pharmaceutical Main Business
Table 96. Guilin Pharmaceutical Latest Developments
Table 97. CAT KHANH Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 98. CAT KHANH Artemisinine Product Offered
Table 99. CAT KHANH Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. CAT KHANH Main Business
Table 101. CAT KHANH Latest Developments
Table 102. Novanat Bioresource Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 103. Novanat Bioresource Artemisinine Product Offered
Table 104. Novanat Bioresource Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Novanat Bioresource Main Business
Table 106. Novanat Bioresource Latest Developments
Table 107. BEEPZ Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 108. BEEPZ Artemisinine Product Offered
Table 109. BEEPZ Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. BEEPZ Main Business
Table 111. BEEPZ Latest Developments
Table 112. KPC Pharmaceuticals Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 113. KPC Pharmaceuticals Artemisinine Product Offered
Table 114. KPC Pharmaceuticals Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. KPC Pharmaceuticals Main Business
Table 116. KPC Pharmaceuticals Latest Developments
Table 117. BIONEXX Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 118. BIONEXX Artemisinine Product Offered
Table 119. BIONEXX Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. BIONEXX Main Business
Table 121. BIONEXX Latest Developments
Table 122. Guangxi xiancaotang Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 123. Guangxi xiancaotang Artemisinine Product Offered
Table 124. Guangxi xiancaotang Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Guangxi xiancaotang Main Business
Table 126. Guangxi xiancaotang Latest Developments
Table 127. Sanofi Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 128. Sanofi Artemisinine Product Offered
Table 129. Sanofi Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Sanofi Main Business
Table 131. Sanofi Latest Developments
Table 132. Natural Bio-engineering Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 133. Natural Bio-engineering Artemisinine Product Offered
Table 134. Natural Bio-engineering Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Natural Bio-engineering Main Business
Table 136. Natural Bio-engineering Latest Developments
Table 137. Kerui nanhai Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 138. Kerui nanhai Artemisinine Product Offered
Table 139. Kerui nanhai Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Kerui nanhai Main Business
Table 141. Kerui nanhai Latest Developments
List of Figures
Figure 1. Picture of Artemisinine
Figure 2. Artemisinine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisinine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Artemisinine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Artemisinine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Extraction from Artemisia annua
Figure 10. Product Picture of Semisynthetic Artemisinine
Figure 11. Global Artemisinine Sales Market Share by Type in 2021
Figure 12. Global Artemisinine Revenue Market Share by Type (2017-2022)
Figure 13. Artemisinine Consumed in Injections
Figure 14. Global Artemisinine Market: Injections (2017-2022) & (K Units)
Figure 15. Artemisinine Consumed in Tablets
Figure 16. Global Artemisinine Market: Tablets (2017-2022) & (K Units)
Figure 17. Artemisinine Consumed in Others
Figure 18. Global Artemisinine Market: Others (2017-2022) & (K Units)
Figure 19. Global Artemisinine Sales Market Share by Application (2017-2022)
Figure 20. Global Artemisinine Revenue Market Share by Application in 2021
Figure 21. Artemisinine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Artemisinine Revenue Market Share by Company in 2021
Figure 23. Global Artemisinine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Artemisinine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Artemisinine Sales Market Share by Region (2017-2022)
Figure 26. Global Artemisinine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Artemisinine Sales 2017-2022 (K Units)
Figure 28. Americas Artemisinine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Artemisinine Sales 2017-2022 (K Units)
Figure 30. APAC Artemisinine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Artemisinine Sales 2017-2022 (K Units)
Figure 32. Europe Artemisinine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Artemisinine Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Artemisinine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Artemisinine Sales Market Share by Country in 2021
Figure 36. Americas Artemisinine Revenue Market Share by Country in 2021
Figure 37. United States Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Artemisinine Sales Market Share by Region in 2021
Figure 42. APAC Artemisinine Revenue Market Share by Regions in 2021
Figure 43. China Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Artemisinine Sales Market Share by Country in 2021
Figure 50. Europe Artemisinine Revenue Market Share by Country in 2021
Figure 51. Germany Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Artemisinine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Artemisinine Revenue Market Share by Country in 2021
Figure 58. Egypt Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Artemisinine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Artemisinine in 2021
Figure 64. Manufacturing Process Analysis of Artemisinine
Figure 65. Industry Chain Structure of Artemisinine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...